首页 | 本学科首页   官方微博 | 高级检索  
检索        

论血液灌流联合血液透析治疗慢性肾功能衰竭的临床观察
引用本文:李强,邓彪,李小红,郑惠兴,曾春媛.论血液灌流联合血液透析治疗慢性肾功能衰竭的临床观察[J].现代医院,2006,6(1):15-16.
作者姓名:李强  邓彪  李小红  郑惠兴  曾春媛
作者单位:博罗县人民医院,广东博罗,516100
摘    要:目的比较血液透析(HD)和血液灌流与血液透析串联(HP/HD)两种方法的疗效。方法维持性HD的慢性肾功能衰竭(CRF)患者进行HP/HD4小时与HD4小时进行比较。结果HD和HP/HD均能清除中、小分子。HP/HD与HD对清除小分子无差别。HP/HD清除中分子(MMS)优于HD。结论HP/HD治疗临床症状改善效果优于HD。

关 键 词:慢性肾衰  血液透析  血液灌流  中分子

THE CLINICAL EFFECT OF HEMODIALYSIS COMBINED WITH HEMOPERFUSION IN THE TREATMENT OF CHRONIC RENAL FAILURE
Li Qiang , Deng Biao , Li Xiao-hong , et al.THE CLINICAL EFFECT OF HEMODIALYSIS COMBINED WITH HEMOPERFUSION IN THE TREATMENT OF CHRONIC RENAL FAILURE[J].Modern Hospital,2006,6(1):15-16.
Authors:Li Qiang  Deng Biao  Li Xiao-hong  
Abstract:Objective To compare the curative effect of hemodialysis (HD) with hemoperfusion combined hemodialysis (HP/HD). Methods 4.0 hours' HP/HD is compared with 4.0 hours' HD in maintaining HD patient with chronic renal failure (CRF). Results HP/HD and HD can eliminate moderate and small molecular, there is no difference between HP/HD and HD. HP/HD is better than HD in eliminating moderate molecular substance. Conclusion HP/HD is superior to HD in improvement of clinical symptom.
Keywords:Chronic renal failure  Hemodialysis  Hemoperfusion  Moderate molecular substance
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号